{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:06:28Z","timestamp":1762527988075,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ajoc.2022.101259","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T23:24:27Z","timestamp":1642634667000},"page":"101259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Bell's palsy following COVID-19 vaccine administration in HIV+ patient"],"prefix":"10.1016","volume":"25","author":[{"given":"Caroline C.","family":"Mussatto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neeti","family":"Alapati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Pfizer-BioNTech COVID-19 Vaccine Emergency Use Authorization Review Memorandum","key":"10.1016\/j.ajoc.2022.101259_bib1"},{"key":"10.1016\/j.ajoc.2022.101259_bib2","series-title":"Harrison's Principles of Internal Medicine, 20e","article-title":"Trigeminal neuralgia, Bell's palsy, and other cranial nerve disorders","author":"Beal","year":"2018"},{"issue":"4","key":"10.1016\/j.ajoc.2022.101259_bib3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell's palsy and SARS-CoV-2 vaccines","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"15","key":"10.1016\/j.ajoc.2022.101259_bib4","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.vaccine.2016.05.023","article-title":"Facial nerve palsy including Bell's palsy: case definitions and guidelines for collection, analysis, and presentation of immunisation safety data","volume":"35","author":"Rath","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ajoc.2022.101259_bib5","series-title":"The Atlas of Emergency Medicine, 5e","article-title":"Facial nerve palsy","author":"Jauch","year":"2021"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101259_bib6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"year":"2012","series-title":"Adverse Effects of Vaccines: Evidence and Causality","key":"10.1016\/j.ajoc.2022.101259_bib7"},{"issue":"49 Pt B","key":"10.1016\/j.ajoc.2022.101259_bib8","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1016\/j.vaccine.2017.09.032","article-title":"Post-licensure safety surveillance study of routine use of quadrivalent meningococcal diphtheria toxoid conjugate vaccine","volume":"35","author":"Hansen","year":"2017","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.ajoc.2022.101259_bib9","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS) United States, 1991-2001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajoc.2022.101259_bib10","doi-asserted-by":"crossref","first-page":"100217","DOI":"10.1016\/j.bbih.2021.100217","article-title":"Bell's Palsy after second dose of Pfizer COVID-19 vaccination in a patient with history of recurrent Bell's palsy","volume":"13","author":"Repajic","year":"2021","journal-title":"Brain Behav Immun Health"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101259_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"issue":"27","key":"10.1016\/j.ajoc.2022.101259_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajoc.2022.101259_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00415-021-10462-4","article-title":"Bell\u2019s palsy following COVID-19 vaccination","volume":"268","author":"Colella","year":"2021","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101259_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2007.10.043","article-title":"All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization","volume":"26","author":"Rath","year":"2007","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.ajoc.2022.101259_bib15","first-page":"1397","article-title":"Neurologic complications of human immunodeficiency virus infection","volume":"24","author":"Saylor","year":"2018","journal-title":"Continuum Neuroinfectious Disease"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101259_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s40506-020-00228-3","article-title":"Neurologic complications of acute HIV infection","volume":"12","author":"Holroyd","year":"2020","journal-title":"Curr Treat Options Infect Dis"},{"issue":"1","key":"10.1016\/j.ajoc.2022.101259_bib17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","article-title":"Bell\u2019s palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"22","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ajoc.2022.101259_bib18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijid.2021.08.071","article-title":"Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database","volume":"111","author":"Sato","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"3","key":"10.1016\/j.ajoc.2022.101259_bib19","first-page":"143","article-title":"Peripheral facial nerve palsy following BNT162b2 (COVID-19) vaccination","volume":"23","author":"Shemer","year":"2021","journal-title":"Isr Med Assoc J"},{"issue":"9","key":"10.1016\/j.ajoc.2022.101259_bib20","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamainternmed.2021.2219","article-title":"Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the world health organization pharmacovigilance database","volume":"181","author":"Renoud","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"14","key":"10.1016\/j.ajoc.2022.101259_bib21","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:01:02Z","timestamp":1762527662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"alternative-id":["S2451993622000056"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101259","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bell's palsy following COVID-19 vaccine administration in HIV+ patient","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101259"}}